A jump in natriuretic peptide levels over several years in middle-aged adults points to worsened long-term risks for incident heart failure (HF) and death. But their predicted long-term survival ...

Scientists are developing a blood test to identify individuals at high risk for hypertrophic cardiomyopathy (HCM), the ...

Novo Nordisk A/S has identified C-type natriuretic peptide (CNP) compounds reported to be useful for the treatment of achondroplasia and heart failure.

Scientists develop new blood test to identify individuals at high risk of developing hypertrophic cardiomyopathy, most common ...